Due to the overwhelming positive feedback in response to our "HANA Oncolyzer" research results that we achieved with our project partner Charité, we decided to transfer the results to the SAP Innovation Center Potsdam for building a generic software solution starting in QII/2012. In that way, we believe that our results will be soon accessible by users worldwide. As a result, researchers and physicians from various disciplines will benefit from our research on in-memory technology to analyze medical data in real time. For example, they will be able to proof hypotheses per patient individually in an interactive manner while involving all relevant patient data at a time for decision taking.

The organizational changes in the healthcare sector require increasing support by proper IT techniques and procedures. Data needs to be available in real-time at any location — even worldwide — on mobile devices to support efforts of researchers and medical doctors. The immense increase of knowledge about cancer requires the detailed analysis of biological and genetic mutations of cancer cells to make only these harmful cells the target of future treatments and to reduce side effects. Until recently, common and unspecific therapies were applied to heal cancer. Meanwhile, treatments for specific genetic mutations are possible to support personalized medicine. "The HANA Oncolyzer highlights the potentials of the in-memory technology. It is the technical for real-time analysis of enterprise and medical data as well", says Cafer Tosun head of the SAP Innovation Center Potsdam. Research institutes and university hospital support HANA Oncolyzer by building the basis for a flexible exchange of information about efficiency of medicines and treatments. In the near future, the tumor's DNA of all cancer patients needs to be analyzed to support specific patient therapies. These analyses result in medical data in amount of multiple terabytes. "These data need to be analyzed regarding mutations and anomalies in real-time", says Dr. Christian Regenbrecht at the institute of pathology at the Charité Berlin. As one of the aims the research prototype HANA Oncolyzer was developed at our chair in cooperation with SAP's Innovation Center in Potsdam.